Share Market Update – Sun Pharma Share Price Target 2025

Sun Pharma Share Price Target 2025:- Sun Pharma is one of India’s leading pharmaceutical companies, known for its strong presence in the global generics and specialty drug markets. The company’s share price target for 2025 will depend on several factors, including new product launches, regulatory approvals, and expansion in key markets like the U.S. and Europe.  Sun Pharma Share Price on NSE as of 13 February 2025 is 1,721.95 INR.

Sun Pharmaceutical Industries Ltd: Current Market Overview

• Open: 1,700.00
• High: 1,725.45
• Low: 1,699.95
• Mkt cap: 4.13LCr
• P/E ratio: 36.08
• Div yield: 0.90%
• 52-wk high: 1,960.35
• 52-wk low: 1,377.20

Sun Pharma Share Price Chart

Sun Pharma Share Price Target 2025 (Prediction)

Sun Pharma Shareholding Pattern

• Promoters: 54.48%
• FII: 18.05%
• DII: 18.55%
• Public: 8.92%

Key Factors Affecting Sun Pharma Share Price Growth

• Strong Global Presence – Sun Pharma’s well-established global network, particularly in the U.S. and emerging markets, supports its revenue growth and enhances its competitive edge.

• New Product Launches – The company’s focus on research and development (R&D) leads to the launch of innovative drugs, boosting sales and market share.

• Expansion in Specialty Drugs – Sun Pharma’s shift towards high-margin specialty drugs, particularly in dermatology and ophthalmology, is a key driver for profitability and growth.

• Regulatory Approvals & Compliance – Timely approvals from regulatory bodies like the U.S. FDA for new drugs and manufacturing facilities can significantly influence its share price.

• Strategic Acquisitions & Partnerships – Mergers, acquisitions, and collaborations with global pharmaceutical firms help Sun Pharma expand its product portfolio and market reach.

Risks and Challenges for Sun Pharma Share Price

• Regulatory Hurdles – Any delay or rejection of drug approvals by the U.S. FDA or other regulatory bodies can impact product launches and revenue growth.

• Pricing Pressure – Generic drug pricing in key markets like the U.S. remains competitive, affecting profit margins and overall financial performance.

• Legal & Compliance Risks – Ongoing lawsuits, intellectual property disputes, or non-compliance with global regulations can lead to financial penalties and reputation damage.

• R&D and Innovation Risks – High investments in research and development do not always guarantee successful new drug launches, which can impact future growth prospects.

• Currency & Market Fluctuations – As a global pharmaceutical company, Sun Pharma is exposed to foreign exchange fluctuations and economic downturns in international markets, which may affect earnings.

Read Also:- Share Market Update – Exicom Share Price Target 2025